INVX (NYSE) insider files Rule 144 to sell 18,837 shares

Rhea-AI Filing Summary

INVX disclosure: A Rule 144 notice reports 18,837 common shares to be sold by the reporting person tied to a 01/01/2024 stock award. The filing lists prior permitted sales of 13,241 shares on 01/14/2026 for $331,025.00 and 13,241 shares on 02/23/2026 for $357,507.00. The securities are listed on NYSE and the covering notice is dated 02/24/2026.

Insights

Securities Compliance Attorney

Routine Rule 144 notice reporting planned resale of restricted shares.

The filing identifies 18,837 common shares linked to a 01/01/2024 stock award as the amount to be sold under Rule 144. It also records two permitted sales of 13,241 shares each on 01/14/2026 and 02/23/2026, with proceeds of $331,025.00 and $357,507.00, respectively.

Timing and exact distribution mechanics are not detailed beyond the Rule 144 notice date of 02/24/2026. Subsequent Form 4/Form 144 amendments or broker reporting will show actual transaction timing and settlement details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	18837	536854.50	68927791	02/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Stock Award	Issuer			18837	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Anderson 19120 KENSWICK DRIVE Humble TX 77338	Common	01/14/2026	13241	331025.00
Adam Anderson 19210 KENSWICK DRIVE Humble TX 77338	Common	02/23/2026	13241	357507.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does INVX's Form 144 disclose?

It discloses intent to sell 18,837 common shares tied to a 01/01/2024 stock award, with the notice dated 02/24/2026. The filing also lists two prior permitted sales in 01/2026 and 02/2026.

Who reported the sales on the INVX filing?

The filing shows sales attributed to an individual named Adam Anderson, including 13,241 shares sold on 01/14/2026 and 13,241 shares sold on 02/23/2026, with the stated proceeds for each sale.

How much did recent INVX sales generate?

The two recent permitted sales show proceeds of $331,025.00 on 01/14/2026 and $357,507.00 on 02/23/2026, each for 13,241 shares as listed in the filing.

Are the shares listed for sale by INVX registered or restricted?

The filing links the 18,837 shares to a 01/01/2024 stock award, indicating they are restricted shares being offered under Rule 144 for resale as disclosed in the notice.

On which exchange are the INVX shares traded?

The filing indicates the securities are listed on the NYSE and the Form 144 notice carries the date 02/24/2026, per the provided excerpt.